In contrast, IRS-4 has been shown to be overexpressed in benign proliferative lesions such as uterine leiomyomas [7] and subungual exostosis [8], as well as in malignant diseases such as breast cancer [9], leukemia [10], lung cancer [4,11], and colorectal cancer [12,13]. This evidence concerns the gene IRS4 and lung cancer.